Breaks Categories: News

TuesdayNov 10, 2020 1:43 pm

NetworkNewsBreaks – InvestorBrandNetwork Announces New Stock2Me Podcast Episode Featuring Well-Known Author John Truman Wolfe

InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, has released its latest Stock2Me Podcast featuring John Truman Wolfe. Wolfe has authored two best-selling and international award-winning books: “The Coming Financial Crisis: A Look Behind the Wizard's Curtain” and “The 99 Strongest Banks in America.” Wolfe is also the editor and publisher of a monthly newsletter, titled “Strategic Financial Intelligence,” which focuses on investing, politics and the economy. During The Stock2Me Podcast episode, hosted by IBN’s Stuart Smith, Wolfe discussed the continued rise in mainstream appeal of decentralized cryptocurrencies following the launch of bitcoin in January 2009 as…

Continue Reading

TuesdayNov 10, 2020 1:38 pm

NetworkNewsBreaks – Creatd Inc. (NASDAQ: CRTD) to Discuss Q3 Financials, Business Update During Webcast

Creatd (NASDAQ: CRTD), the parent company of Vocal, a proprietary technology platform for creators of all types, will hold a Nov. 17 webcast. During the webcast, company officials will discuss Creatd’s third-quarter 2020 financial numbers as well as provide key updates about business updates, including an overview of CRTD’s freemium creator and paid subscription metrics. In addition, the company will host a Q&A following the discussion of the financials. Questions can be submitted via the webcast portal or emailed ([email protected]) prior to the webcast. Creatd anticipates releasing the company’s financial results after the market closes on Monday, Nov. 16, 2020. The…

Continue Reading

TuesdayNov 10, 2020 1:10 pm

NetworkNewsBreaks – Antibe Therapeutics Inc. (TSXV: ATE) (OTCQB: ATBPF) Graduates to the TSX

Antibe Therapeutics (TSXV: ATE) (OTCQB: ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop safer medicines for pain and inflammation, today announced its receipt of final approval from the Toronto Stock Exchange (“TSX”) to list its common shares on the TSX. According to the update, Antibe’s shares will commence TSX trading under the company’s existing ticker symbol “ATE” at market open on Thursday, November 12, 2020. “We are excited to graduate to the TSX, as it represents a further step in reaching the broader investment community while increasing liquidity for our shareholders,” said Dan Legault, Antibe’s…

Continue Reading

TuesdayNov 10, 2020 12:49 pm

NetworkNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) to Present at Virtual Fall Investor Summit

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D metal printing industry, today announced that management will present at the Virtual Fall Investor Summit taking place from November 16 - 18, 2020. According to the update, Sigma Labs CEO Mark K. Ruport is scheduled to host a virtual presentation at 9:00 a.m. ET on Wednesday, November 18, 2020, and will also participate in one-on-one meetings throughout the day. Sigma’s presentation will highlight its new PrintRite3D Lite In-Process Quality Assurance system, IN4.OS Strategic Alliance for Factories of the Future and recent contract awards. Interested parties…

Continue Reading

TuesdayNov 10, 2020 12:25 pm

NetworkNewsBreaks – Cannabis Strategic Ventures (NUGS) Releases Quarterly Financials, Reports More Than 90% Increase in Sales

Cannabis Strategic Ventures (OTCQB:NUGS), an emerging leader in the U.S. cannabis marketplace, has announced its quarterly financial report for the period ending Sept. 30, 2020. A highlight of the report was the $6.4 million in sales for the period, a number that is up nearly 100% compared to the previous quarter, which totaled $3.3 million. Overall, the financial numbers indicate the company’s vigorous growth and wide-ranging expansion as it strengthens its position within the rapidly growing California cannabis marketplace. The increase in sales between the two quarters was more than 90%; the $6.4 million in sales represented a year-over-year increase…

Continue Reading

TuesdayNov 10, 2020 11:59 am

NetworkNewsBreaks – The Movie Studio Inc. (MVES), VIVA Entertainment Group Inc. (OTTV) Enter Strategic Partnership, Service Agreement

The Movie Studio (OTC: MVES) today announced its entry into a strategic partnership and service agreement with VIVA Entertainment Group (OTC: OTTV) to align the mutually beneficial assets and associations of the two publicly traded companies. According to the update, the collaboration specifically focuses on potential cross advertising between the companies’ over-the-top (“OTT”) platforms and apps, content licensing, production and distribution services, as well as associations of current intellectual properties during the term of the agreement. “We are extremely excited about the strategic partnership with VIVA Entertainment, and the symbiotic approach that we both see regarding OTT platforms synchronizes with…

Continue Reading

TuesdayNov 10, 2020 11:35 am

NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Expands Scientific Advisory Board with Strategic Appointment

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the addition of George K. Gittes, MD to its Scientific Advisory Board (“SAB”). According to the update, Dr. Gittes is the inventor of GNPX’s licensed diabetes gene therapy technology that is currently in development and serves as the chief of pediatric surgery and surgeon-in-chief emeritus at the UPMC Children’s Hospital of Pittsburgh. “We are delighted to have Dr. Gittes join our Scientific Advisory Board as Genprex continues to advance its diabetes program,” said Rodney Varner, Genprex’s president and chief…

Continue Reading

TuesdayNov 10, 2020 11:12 am

NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Enters LOI with Asymchem for MS1819 Development, Production

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced its entry into a binding letter of intent (“LOI”) with Asymchem, a leading global contract development and manufacturing service (“CDMO”) provider, for the development and production of MS1819 for the treatment of exocrine pancreatic insufficiency. Under the agreement, Asymchem will implement fermentation, verify protein expression and ultimately fine-tune the technology suitable for production of MS1819. Asymchem will be responsible for sourcing all materials required for the program under Current Good Manufacturing Practice (“cGMP”) regulatory conditions. “With a fairly competitive landscape for CDMOs,…

Continue Reading

TuesdayNov 10, 2020 10:41 am

NetworkNewsBreaks – LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Selected to Present at Upcoming Investor Conferences

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is slated to present at two upcoming investor conferences. Representing LexaGene at the conferences will be founder and CEO Jack Regan. Regan will be a presenter at the Investor Summit Group Conference held Nov. 18, 2020, at 1:30 p.m.  and at the Canaccord Genuity 2020 Medical Technologies & Diagnostics Forum scheduled for Nov. 19, 2020, at 10 a.m. EST; additional information about these conferences and Regan’s presentations is available on the event page of LexaGene’s website.“This is an excellent opportunity for the Company…

Continue Reading

TuesdayNov 10, 2020 10:38 am

NetworkNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Reports Annual General Meeting of Shareholders Voting Results

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a global diversified portfolio of distinct businesses, products and brands, today announced detailed voting results from its 2020 Annual General Meeting of Shareholders that was held on November 9, 2020. Among other highlights, Michael La Brier, Beena Goldenberg, Jackie Poriadjian-Asch, Ronald Factor, Colin Moore and Kenneth R. McKinnon were elected to the company’s board of directors. The newly elected board members will serve until the next annual meeting of shareholders, or until their successors are elected or appointed. In addition, KPMG LLP were reappointed as auditors of the company to hold…

Continue Reading